British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...

The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...

The number of significant shareholder protests has more than doubled so far this year compared with a year ago, with 11 FTSE ...

Irritable Bowel Syndrome Treatment Market PORTLAND, OR, UNITED STATES, August 11, 2025 /EINPresswire / -- The global irritable bowel syndrome ...

Urgent need for standardization in dental education and clinical practices: Dr Ashok Dhoble: Shardul Nautiyal, Mumbai Monday, August 11, 2025, 08:00 Hrs [IST] Dr Ashok Dhoble, sec ...

Detailed price information for Ideaya Biosciences Inc (IDYA-Q) from The Globe and Mail including charting and trades.

A new pill that combats antibiotic-resistant strains of gonorrhoea has inched closer to approval in the US, after the US Food and Drug Administration (FDA) accepted GSK’s gepotidacin for priority ...

GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...

GSK (GSK) stock in focus as the company bid to expand use of oral antibiotic agent gepotidacin for urogenital gonorrhea is granted FDA priority review. Read more here.

The UK's FTSE 100 index showed a modest gain, driven by healthcare and consumer shares. However, concerns over upcoming ...

Harvey Jones takes a look at 2 FTSE 100 income stocks that investors are snubbing right now to see whether there's a big ...

As of 0715 GMT, the blue-chip index FTSE 100 gained 0.3% and the British pound rose 0.09% against the dollar to above 1.34.